ULK1 promotes oxaliplatin resistance of colon cancer via phosphorylation of Bax S184
{{output}}
Background: Oxaliplatin resistance continues to undermine therapeutic outcomes in colon cancer (CC). Recent investigations point to unc-51 like kinase 1 (ULK1)-mediated disruption of apoptotic pathways as a potential driver of ch... ...
